Aetna (AET) Cut to “Hold” at Argus

Aetna (NYSE:AET) was downgraded by analysts at Argus from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday.

AET has been the subject of a number of other research reports. Zacks Investment Research upgraded Aetna from a “hold” rating to a “buy” rating and set a $174.00 target price for the company in a research report on Thursday, October 12th. Jefferies Group boosted their target price on Aetna from $165.00 to $185.00 and gave the stock a “hold” rating in a research report on Wednesday, November 1st. BMO Capital Markets started coverage on Aetna in a research report on Monday, October 16th. They issued a “market perform” rating and a $175.00 target price for the company. Raymond James Financial upgraded Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 target price for the company in a research report on Friday, November 3rd. Finally, Morgan Stanley boosted their target price on Aetna from $172.00 to $179.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. Twelve investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Aetna has a consensus rating of “Buy” and an average price target of $174.14.

Aetna (NYSE:AET) opened at $178.69 on Wednesday. Aetna has a twelve month low of $116.04 and a twelve month high of $192.37. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $58,274.07, a PE ratio of 17.50, a PEG ratio of 1.63 and a beta of 0.61.

Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The company had revenue of $14.99 billion during the quarter, compared to analyst estimates of $15.12 billion. During the same quarter in the previous year, the firm earned $2.07 earnings per share. Aetna’s revenue was down 5.0% on a year-over-year basis. research analysts forecast that Aetna will post 9.78 EPS for the current fiscal year.

In other Aetna news, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the sale, the president now owns 64,261 shares in the company, valued at $10,404,498.51. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Several institutional investors have recently made changes to their positions in AET. Bruderman Asset Management LLC bought a new position in shares of Aetna during the second quarter valued at approximately $106,000. Lloyds Banking Group plc bought a new position in shares of Aetna during the third quarter valued at approximately $106,000. Moisand Fitzgerald Tamayo LLC bought a new position in shares of Aetna during the third quarter valued at approximately $116,000. Westside Investment Management Inc. raised its holdings in shares of Aetna by 53.5% during the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock valued at $177,000 after acquiring an additional 400 shares in the last quarter. Finally, Phocas Financial Corp. bought a new position in shares of Aetna during the second quarter valued at approximately $182,000. Institutional investors own 88.03% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://stocknewstimes.com/2017/12/06/aetna-aet-cut-to-hold-at-argus.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply